Stated plainly: sterile water for injection · ten weeks.
The comparison I want does not seem to exist anywhere in a form I can evaluate.
I have read the arguments for each and they do not engage with each other.
Which axes does this decision turn on?
10 weeks is 70 days and, on a weekly schedule, 10 punctures of one stopper — 2.5 times the twenty-eight-day convention for a preserved multi-dose vial. The case turns on what happens between the withdrawals rather than during them, and two clocks are running: a microbiological one the preservative addresses, and a chemical one it does not. With no preservative, 10 entries over 70 days is 10 unprotected openings, and the convention that would otherwise cover them is not available to you. The case for it is chemical simplicity; the case against is that the microbiological clock runs in hours. 10 punctures is also 10 coring events on one stopper and a headspace that grows with every draw, neither of which appears on any certificate. Aliquoting at reconstitution retires both arguments at once: it turns 10 entries into one, and the remaining question becomes freezer stability rather than preservative efficacy.
Bacteriostatic water is water for injection containing roughly 0.9 per cent benzyl alcohol as a preservative, and its purpose is to suppress microbial growth in a vial opened repeatedly.
Opened vials accumulate bioburden with every pierce, and benzyl alcohol suppresses the growth of the organisms that get in but does not prevent them getting in.
| Configuration | Dead volume | Loss at 5 mg/mL | Over 20 draws |
|---|---|---|---|
| Fixed-needle insulin syringe | 3–5 µL | 15–25 µg | 0.3–0.5 mg |
| Low-dead-space, detachable | <2 µL | <10 µg | <0.2 mg |
| Standard luer-lock + 30G | 35–60 µL | 175–300 µg | 3.5–6 mg |
| Luer-lock + 21G drawing needle | 70–100 µL | 350–500 µg | 7–10 mg |
The relevant detail is that a vial that has been sitting out at room temperature is not sterile and bacteriostatic water does not make it so.
Benzyl alcohol efficacy in suppressing common skin and environmental bacteria is well-established and published.
The practical summary: use bacteriostatic water for multi-withdrawal, store refrigerated, and respect the 28-day limit.
Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.
Browse resultsOn the detail: the distinction that resolves most of these questions is understanding that bacteriostatic water is a preservative system for multi-withdrawal presentations, not a substitute for aseptic technique.
The failure mode is bioburden accumulating faster than the benzyl alcohol suppresses it, which happens if the initial inoculum is large or the environment is filthy.
Put another way, different manufacturers of "bacteriostatic water" vary in their formulation, and some are better than others — brand matters.
The 28-day beyond-use convention derives from USP standards, which base it on microbiological risk rather than on any one specific study.
Do not use bacteriostatic water as a substitute for aseptic technique.
Concretely, if the supplier documentation specifies bacteriostatic water, there is a reason, and that reason is almost always "this is for multiple-withdrawal use."
Benzyl alcohol concentration at 0.9 per cent is the approved level — lower concentrations do not provide the same suppression and higher concentrations are unnecessarily irritant.
The osmolarity of bacteriostatic water is roughly that of normal saline, which makes it generally safe for subcutaneous or parenteral use.
Worth noting that some people have reactions to benzyl alcohol, which is worth knowing if you are going to inject.
If you are doing single-withdrawal use, sterile water is the better choice.
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.